Equine Familial Isolated Hypoparathyroidism (EFIH)
Gene or Region: RAPGEF5
Reference Variant: C
Mutant Variant: A
Affected Breeds: Thoroughbred, Thoroughbred crosses, other Thoroughbred-influenced breeds
Research Confidence: High - Strong association in studied population
Explanation of Results: efih/efih = homozygous for Equine Familial Isolated Hypoparathyroidism, trait expressed efih/n = heterozygous for Equine Familial Isolated Hypoparathyroidism, carrier n/n = no variant detected
Equine Familial Isolated Hypoparathyroidism (EFIH): What You Need to Know Before Breeding Thoroughbreds
Equine Familial Isolated Hypoparathyroidism (EFIH) is a fatal genetic disorder identified in Thoroughbred foals, characterized by low blood calcium levels leading to muscle stiffness, seizures, and, ultimately, death. The condition is inherited in an autosomal recessive manner, meaning that foals with two copies of the causative genetic variant are affected.
EFIH manifests in foals up to 35 days old, presenting with symptoms such as involuntary muscle contractions, a stiff gait progressing to an inability to stand, seizures, fever, and rapid pulse. These clinical signs are associated with low blood calcium concentrations and inadequately low or normal parathyroid hormone levels. Necropsy findings often reveal underdeveloped or absent parathyroid glands.
Gene Information
The genetic basis for EFIH is a nonsense variant in the Rap Guanine Nucleotide Exchange Factor 5 gene (RAPGEF5) that replaces a serine in the protein product with a stop codon (c.2624C>A p.Ser875*), leading to a truncated protein with decreased functionality. RAPGEF5 plays a crucial role in intracellular signaling pathways, particularly those involved in cyclic AMP (cAMP)-dependent signaling and calcium homeostasis. In affected horses, this variant in RAPGEF5 disrupts normal parathyroid gland function, impairing PTH synthesis and secretion.
References
Rivas, V. N., Magdesian, K. G., Fagan, S., Slovis, N. M., Luethy, D., Javsicas, L. H., Caserto, B. G., Miller, A. D., Dahlgren, A. R., Peterson, J., Hales, E. N., Peng, S., Watson, K. D., Khokha, M. K., & Finno, C. J. (2020). A nonsense variant in Rap Guanine Nucleotide Exchange Factor 5 (RAPGEF5) is associated with equine familial isolated hypoparathyroidism in Thoroughbred foals. PLoS Genetics, 16(9), e1009028. doi: 10.1371/journal.pgen.1009028
More Horse Health
"Warmblood" Fragile Foal Syndrome
"Warmblood" fragile foal syndrome (FFS) is a connective tissue disorder resulting in joint laxity and extremely thin skin that is only loosely connected to the body. The skin is easily torn, resulting in lacerations, hematomas, and seromas across the foal. Affected foals are euthanized shortly after birth.
Androgen Insensitivity Syndrome
Androgen Insensitivity Syndrome (AIS) is an X-linked disorder of sexual development resulting in a female horse with XY chromosomes. Horses with AIS exhibit stallion-like behavior such as agression toward other horses, Flehman response and vocalization toward cycling mares.
Cerebellar Abiotrophy
Cerebellar Abiotrophy (CA) is a degenerative neurological disorder, due to the death of neurons in the brain. Symptoms (head tremors, lack of coordination, wide stances, exaggerated gain, difficulty rising and startling easily), typically appear in foals between six weeks and four months of age.
Chronic Idiopathic Anhidrosis Risk
Chronic Idiopathic Anhidrosis Risk (CIA) is the inability to sweat in response to increased body temperature, (AKA "non-sweater"). This condition is dangerous and sometimes life-threatening for horses, who rely on sweating for 65-70% of their temperature regulation.